Skip to content

CDR

Pfizer’s Xeljanz arthritis drug approved

Pfizer Inc. has been cleared by the Food and Drug Administration to market Xeljanz, a medication for rheumatoid arthritis. The company said Wednesday that Xeljanz (tofacitinib citrate) represents the first new oral disease-modifying antirheumatic drug for rheumatoid arthritis (RA) in over 10 years.

DJ duo NERVO becomes new CoverGirls

Electronic dance music DJ duo NERVO has been signed up as the newest CoverGirls. The Procter & Gamble makeup brand said the music stars, who are sisters, bring a "beauty with an edge" flair and make their public debut as CoverGirls on Wednesday "spinning in style" at a CoverGirl-sponsored event in

Walmart Part D plan: Hypertension drugs for a penny

Walmart Part D plan: Hypertension drugs for a penny

Next year, Walmart will enable members of its co-branded Medicare Part D plan with Humana to get common hypertension medications for 1 cent each. The discount store giant and health insurer said Wednesday that beginning in 2013, members of the Humana Walmart-Preferred Rx Plan will have access to 10

90-day refills spur Rx adherence, Walgreens finds

Research from Walgreen Co. revealed that Medicaid patients with 90-day refills showed better medication adherence than those with 30-day refills. Walgreens said Wednesday the study also found that Medicaid patients with 90-day refills had greater persistency, nominal wastage and more cost savings.

NACDS Foundation helps promote heart health

Grants from the National Association of Chain Drug Stores Foundation made possible 65 health fairs that served 3,500 patients as part of Million Hearts, a public-private partnership to help prevent 1 million heart attacks and strokes over the next five years.